the DT B-NP Friendly NNP I-NP Skies NNPS I-NP -- : O free JJ B-NP first-class JJ I-NP travel NN I-NP , , O and CC O $ $ B-NP 20,000 CD I-NP a DT B-NP year NN I-NP for IN B-PP life NN B-NP as IN B-ADVP well RB I-ADVP . . O Conceivably RB B-ADVP , , O in IN B-PP a DT B-NP scaled-back JJ I-NP buy-out NN I-NP , , O they PRP B-NP could MD B-VP be VB I-VP bumped VBN I-VP back RB B-ADVP to TO B-PP coach NN B-NP seats NNS I-NP for IN B-PP life NN B-NP . . O Thomas NNP B-NP H. NNP I-NP Johnson NNP I-NP , , O president NN B-NP of IN B-PP the DT B-NP Coatedboard NNP I-NP division NN I-NP of IN B-PP Mead NNP B-NP Corp. NNP I-NP , , O was VBD B-VP named VBN I-VP president NN B-NP of IN B-PP Manville NNP B-NP Forest NNP I-NP Products NNP I-NP Corp. NNP I-NP , , O a DT B-NP Manville NNP I-NP unit NN I-NP , , O and CC O senior JJ B-NP vice NN I-NP president NN I-NP of IN B-PP Manville NNP B-NP Corp NNP I-NP . . O Mr. NNP B-NP Johnson NNP I-NP succeeds VBZ B-VP Harry NNP B-NP W. NNP I-NP Sherman NNP I-NP , , O who WP B-NP resigned VBD B-VP to TO B-VP pursue VB I-VP other JJ B-NP interests NNS I-NP , , O in IN B-PP both DT B-NP positions NNS I-NP . . O Manville NNP B-NP is VBZ B-VP a DT B-NP building NN I-NP and CC I-NP forest NN I-NP products NNS I-NP concern VBP I-NP . . O US PRP B-NP Facilities NNP I-NP Corp. NNP I-NP said VBD B-VP Robert NNP B-NP J. NNP I-NP Percival NNP I-NP agreed VBD B-VP to TO I-VP step VB I-VP down RB B-ADVP as IN B-PP vice NN B-NP chairman NN I-NP of IN B-PP the DT B-NP insurance NN I-NP holding VBG I-NP company NN I-NP . . O `` `` O There EX B-NP was VBD B-VP a DT B-NP difference NN I-NP of IN B-PP opinion NN B-NP as IN B-PP to TO B-PP the DT B-NP future NN I-NP direction NN I-NP of IN B-PP the DT B-NP company NN I-NP , , O '' '' O a DT B-NP spokeswoman NN I-NP said VBD B-VP . . O Mr. NNP B-NP Percival NNP I-NP declined VBD B-VP to TO I-VP comment VB I-VP . . O In IN B-PP a DT B-NP statement NN I-NP , , O US PRP B-NP Facilities NNPS I-NP said VBD B-VP Mr. NNP B-NP Percival NNP I-NP 's POS B-NP employment NN I-NP contract NN I-NP calls VBZ B-VP for IN B-SBAR him PRP B-NP to TO B-VP act VB I-VP as IN B-PP a DT B-NP consultant NN I-NP to TO B-PP the DT B-NP company NN I-NP for IN B-PP two CD B-NP years NNS I-NP . . O He PRP B-NP will MD B-VP also RB I-VP remain VB I-VP a DT B-NP director NN I-NP , , O US PRP B-NP Facilities NNPS I-NP said VBD B-VP , , O but CC O wo MD B-VP n't RB I-VP serve VB I-VP on IN B-PP any DT B-NP board NN I-NP committees NNS I-NP . . O Mr. NNP B-NP Percival NNP I-NP will MD B-VP be VB I-VP succeeded VBN I-VP on IN B-PP an DT B-NP interim JJ I-NP basis NN I-NP by IN B-PP George NNP B-NP Kadonada NNP I-NP , , O US PRP B-NP Facilities NNPS I-NP chairman NN I-NP and CC I-NP president NN I-NP . . O In IN B-PP the DT B-NP same JJ I-NP statement NN I-NP , , O US PRP B-NP Facilities NNPS I-NP also RB B-ADVP said VBD B-VP it PRP B-NP had VBD B-VP bought VBN I-VP back RB B-ADVP 112,000 CD B-NP of IN B-PP its PRP$ B-NP common JJ I-NP shares NNS I-NP in IN B-PP a DT B-NP private JJ I-NP transaction NN I-NP . . O Terms NNS B-NP were VBD B-VP n't RB I-VP disclosed VBN I-VP . . O The DT B-NP buy-back NN I-NP represents VBZ B-VP about IN B-NP 3 CD I-NP % NN I-NP of IN B-PP the DT B-NP company NN I-NP 's POS B-NP shares NNS I-NP , , O based VBN B-VP on IN B-PP the DT B-NP 3.7 CD I-NP million CD I-NP shares NNS I-NP outstanding JJ B-ADJP as IN B-PP of IN B-PP Sept. NNP B-NP 30 CD I-NP . . O In IN B-PP national JJ B-NP over-the-counter JJ I-NP trading NN I-NP yesterday NN B-NP , , O US PRP B-NP Facilities NNPS I-NP closed VBD B-VP at IN B-PP $ $ B-NP 3.625 CD I-NP , , O unchanged JJ B-ADJP . . O Three CD B-NP leading VBG I-NP drug NN I-NP companies NNS I-NP reported VBD B-VP robust JJ B-NP third-quarter JJ I-NP earnings NNS I-NP , , O bolstered VBN B-VP by IN B-PP strong JJ B-NP sales NNS I-NP of IN B-PP newer JJR B-NP , , I-NP big-selling JJ I-NP prescriptions NNS I-NP drugs NNS I-NP that WDT B-NP provide VBP B-VP hefty JJ B-NP profit NN I-NP margins NNS I-NP . . O Merck NNP B-NP & CC I-NP Co. NNP I-NP reported VBD B-VP a DT B-NP 25 CD I-NP % NN I-NP increase NN I-NP in IN B-PP earnings NNS B-NP ; : O Warner-Lambert NNP B-NP Co. NNP I-NP 's POS B-NP profit NN I-NP rose VBD B-VP 22 CD B-NP % NN I-NP and CC O Eli NNP B-NP Lilly NNP I-NP & CC I-NP Co. NNP I-NP 's POS B-NP net JJ I-NP income NN I-NP rose VBD B-VP 24 CD B-NP % NN I-NP . . O The DT B-NP results NNS I-NP were VBD B-VP in IN B-PP line NN B-NP with IN B-PP analysts NNS B-NP ' POS B-NP expectations NNS I-NP . . O Merck NNP B-NP & CC I-NP Co NNP I-NP . . O Merck NNP B-NP , , O Rahway NNP B-NP , , O N.J. NNP B-NP , , O continued VBD B-VP to TO I-VP lead VB I-VP the DT B-NP industry NN I-NP with IN B-PP a DT B-NP strong JJ I-NP sales NNS I-NP performance NN I-NP in IN B-PP the DT B-NP human NN I-NP and CC I-NP animal NN I-NP health-products NNS I-NP segment VBP I-NP . . O A DT B-NP stronger JJR I-NP U.S. NNP I-NP dollar NN I-NP reduced VBD B-VP third-quarter JJ B-NP and CC I-NP first-nine-month JJ I-NP sales NNS I-NP growth NN I-NP 2 CD B-NP % NN I-NP and CC I-NP 3 CD I-NP % NN I-NP , , O respectively RB B-ADVP . . O International JJ B-NP sales NNS I-NP accounted VBD B-VP for IN B-PP 47 CD B-NP % NN I-NP of IN B-PP total JJ B-NP company NN I-NP sales NNS I-NP for IN B-PP the DT B-NP nine CD I-NP months NNS I-NP , , O compared VBN B-PP with IN B-PP 50 CD B-NP % NN I-NP a DT B-NP year NN I-NP earlier RBR B-ADVP . . O Sales NNS B-NP for IN B-PP the DT B-NP quarter NN I-NP rose VBD B-VP to TO B-PP $ $ B-NP 1.63 CD I-NP billion CD I-NP from IN B-PP $ $ B-NP 1.47 CD I-NP billion CD I-NP . . O Mevacor NNP B-NP , , O Merck NNP B-NP 's POS B-NP new JJ I-NP cholesterol-lowering JJ I-NP drug NN I-NP , , O had VBD B-VP higher JJR B-NP sales NNS I-NP than IN B-SBAR any DT B-NP other JJ I-NP prescription NN I-NP medicine NN I-NP has VBZ B-VP ever RB I-VP achieved VBN I-VP in IN B-PP the DT B-NP U.S. NNP I-NP in IN B-PP the DT B-NP year NN I-NP following VBG B-PP introduction NN B-NP , , O the DT B-NP company NN I-NP said VBD B-VP . . O The DT B-NP drug NN I-NP was VBD B-VP introduced VBN I-VP in IN B-PP West NNP B-NP Germany NNP I-NP this DT B-NP year NN I-NP . . O Intense JJ B-NP competition NN I-NP , , O however RB B-ADVP , , O led VBN B-VP to TO B-PP unit NN B-NP sales NNS I-NP declines NNS I-NP for IN B-PP a DT B-NP group NN I-NP of IN B-PP Merck NNP B-NP 's POS B-NP established VBN I-NP human NN I-NP and CC I-NP animal-health NN I-NP products NNS I-NP , , O including VBG B-PP Aldomet NNP B-NP and CC I-NP Indocin NNP I-NP . . O In IN B-PP New NNP B-NP York NNP I-NP Stock NNP I-NP Exchange NNP I-NP composite JJ I-NP trading NN I-NP yesterday NN B-NP , , O Merck NNP B-NP shares NNS I-NP closed VBD B-VP at IN B-PP $ $ B-NP 75.25 CD I-NP , , O up IN B-ADVP 50 CD B-NP cents NNS I-NP . . O Warner-Lambert NNP B-NP Co NNP I-NP . . O Warner-Lambert NNP B-NP , , O Morris NNP B-NP Plains NNP I-NP , , O N.J. NNP B-NP , , O reported VBD B-VP sales NNS B-NP that WDT B-NP were VBD B-VP a DT B-NP record NN I-NP for IN B-PP any DT B-NP quarter NN I-NP and CC O the DT B-NP eighth JJ I-NP quarter NN I-NP in IN B-PP a DT B-NP row NN I-NP of IN B-PP 20 CD B-NP % NN I-NP or CC I-NP more RBR I-NP per-share JJ I-NP earnings NNS I-NP growth NN I-NP . . O Spurred VBN B-VP by IN B-PP growth NN B-NP in IN B-PP world-wide JJ B-NP sales NNS I-NP of IN B-PP the DT B-NP company NN I-NP 's POS B-NP prescription NN I-NP drugs NNS I-NP , , O Warner-Lambert NNP B-NP said VBD B-VP 1989 CD B-NP will MD B-VP be VB I-VP the DT B-NP best JJS I-NP year NN I-NP in IN B-PP its PRP$ B-NP history NN I-NP , , O with IN B-SBAR per-share JJ B-NP earnings NNS I-NP expected VBN B-VP to TO I-VP increase VB I-VP more JJR B-NP than IN I-NP 20 CD I-NP % NN I-NP to TO B-PP about RB B-NP $ $ I-NP 6.10 CD I-NP . . O Sales NNS B-NP for IN B-PP the DT B-NP quarter NN I-NP rose VBD B-VP to TO B-PP $ $ B-NP 1.11 CD I-NP billion CD I-NP from IN B-PP $ $ B-NP 1.03 CD I-NP billion CD I-NP . . O Prescription-drug NN B-NP world-wide JJ I-NP sales NNS I-NP rose VBD B-VP 9 CD B-NP % NN I-NP in IN B-PP the DT B-NP quarter NN I-NP to TO B-PP $ $ B-NP 340 CD I-NP million CD I-NP ; : O U.S. NNP B-NP sales NNS I-NP rose VBD B-VP 15 CD B-NP % NN I-NP . . O The DT B-NP segment NN I-NP 's POS B-NP growth NN I-NP was VBD B-VP led VBN I-VP by IN B-PP sales NNS B-NP of IN B-PP the DT B-NP cardiovascular JJ I-NP drugs NNS I-NP Lopid NNP B-NP , , O a DT B-NP lipid NN I-NP regulator NN I-NP , , O and CC O Dilzem NNP B-NP , , O a DT B-NP calcium NN I-NP channel NN I-NP blocker NN I-NP . . O World-wide JJ B-NP sales NNS I-NP of IN B-PP Warner-Lambert NNP B-NP 's POS B-NP non-prescription JJ I-NP health-care NN I-NP products NNS I-NP , , O such JJ B-PP as IN I-PP Halls NNP B-NP cough NN I-NP tablets NNS I-NP , , O Rolaids NNP B-NP antacid NN I-NP , , O and CC O Lubriderm NNP B-NP skin NN I-NP lotion NN I-NP , , O increased VBN B-VP 3 CD B-NP % NN I-NP to TO B-PP $ $ B-NP 362 CD I-NP million CD I-NP in IN B-PP the DT B-NP third JJ I-NP quarter NN I-NP ; : O U.S. NNP B-NP sales NNS I-NP rose VBD B-VP 5 NN B-NP % NN I-NP . . O Confectionery JJ B-NP products NNS I-NP sales NNS I-NP also RB B-ADVP had VBD B-VP strong JJ B-NP growth NN I-NP in IN B-PP the DT B-NP quarter NN I-NP . . O World-wide JJ B-NP sales NNS I-NP of IN B-PP Trident NNP B-NP gum NN I-NP , , O Certs NNP B-NP breath NN I-NP mints NNS I-NP , , O and CC O Clorets NNP B-NP gum NN I-NP and CC I-NP breath NN I-NP mints NNS I-NP , , O increased VBN B-VP 12 CD B-NP % NN I-NP to TO B-PP $ $ B-NP 277 CD I-NP million CD I-NP . . O Warner-Lambert NNP B-NP shares NNS I-NP closed VBD B-VP at IN B-PP $ $ B-NP 109.50 CD I-NP a DT B-NP share NN I-NP , , O up IN B-ADVP $ $ B-NP 1.50 CD I-NP , , O in IN B-PP Big NNP B-NP Board NNP I-NP composite JJ I-NP trading NN I-NP yesterday NN B-NP . . O Eli NNP B-NP Lilly NNP I-NP & CC I-NP Co NNP I-NP . . O Lilly NNP B-NP attributed VBD B-VP record NN B-NP third-quarter JJ I-NP and CC I-NP nine-month JJ I-NP results NNS I-NP to TO B-PP world-wide JJ B-NP gains NNS I-NP for IN B-PP pharmaceuticals NNS B-NP , , O medical JJ B-NP instruments NNS I-NP and CC O plant-science NN B-NP products NNS I-NP despite IN B-PP poor JJ B-NP exchange NN I-NP rates NNS I-NP for IN B-PP the DT B-NP dollar NN I-NP that WDT B-NP slowed VBD B-VP sales NNS B-NP abroad RB B-ADVP . . O Earnings NNS B-NP continued VBD B-VP to TO I-VP pace VB I-VP sales NNS B-NP because IN B-PP of IN I-PP a DT B-NP lower JJR I-NP tax NN I-NP rate NN I-NP , , O profit NN B-NP from IN B-PP the DT B-NP renegotiation NN I-NP of IN B-PP the DT B-NP debt NN I-NP instrument NN I-NP received VBD B-VP from IN B-PP Faberge NNP B-NP Inc. NNP I-NP in IN B-PP connection NN B-NP with IN B-PP Lilly NNP B-NP 's POS B-NP sale NN I-NP of IN B-PP Elizabeth NNP B-NP Arden NNP I-NP Inc. NNP I-NP in IN B-PP 1987 CD B-NP , , O and CC O net JJ B-NP proceeds NNS I-NP from IN B-PP the DT B-NP settlement NN I-NP of IN B-PP patent NN B-NP litigation NN I-NP at IN B-PP Lilly NNP B-NP 's POS B-NP Hybritech NNP I-NP Inc. NNP I-NP unit NN I-NP . . O Third-quarter JJ B-NP sales NNS I-NP of IN B-PP the DT B-NP Indianapolis NNP I-NP , , I-NP Ind. NNP I-NP , , I-NP company NN I-NP rose VBD B-VP 11 CD B-NP % NN I-NP to TO B-PP $ $ B-NP 1.045 CD I-NP billion CD I-NP from IN B-PP $ $ B-NP 940.6 CD I-NP million CD I-NP . . O Nine-month JJ B-NP sales NNS I-NP grew VBD B-VP 12 CD B-NP % NN I-NP to TO B-PP $ $ B-NP 3.39 CD I-NP billion CD I-NP from IN B-PP $ $ B-NP 3.03 CD I-NP billion CD I-NP a DT B-NP year NN I-NP earlier RBR B-ADVP . . O Sales NNS B-NP of IN B-PP Prozac NNP B-NP , , O an DT B-NP anti-depressant NN I-NP , , O led VBN B-VP drug-sales NNS B-NP increases NNS I-NP . . O Higher JJR B-NP sales NNS I-NP of IN B-PP pesticides NNS B-NP and CC O other JJ B-NP plant-science NN I-NP products NNS I-NP more JJR B-VP than IN I-VP offset VB I-VP a DT B-NP slight JJ I-NP decline NN I-NP in IN B-PP the DT B-NP sales NNS I-NP of IN B-PP animal-health NN B-NP products NNS I-NP to TO B-VP fuel VB I-VP the DT B-NP increase NN I-NP in IN B-PP world-wide JJ B-NP agricultural JJ I-NP product NN I-NP sales NNS I-NP , , O Lilly NNP B-NP said VBD B-VP . . O Advanced NNP B-NP Cardiovascular NNP I-NP Systems NNP I-NP Inc. NNP I-NP and CC O Cardiac NNP B-NP Pacemakers NNPS I-NP Inc. NNP I-NP units NNS I-NP led VBD B-VP growth NN B-NP in IN B-PP the DT B-NP medical-instrument JJ I-NP systems NNS I-NP division NN I-NP . . O Lilly NNP B-NP shares NNS I-NP closed VBD B-VP yesterday NN B-NP in IN B-PP composite JJ B-NP trading NN I-NP on IN B-PP the DT B-NP Big NNP I-NP Board NNP I-NP at IN B-PP $ $ B-NP 62.25 CD I-NP , , O down RB B-ADVP 12.5 CD B-NP cents NNS I-NP . . O Reuben NNP B-NP Mark NNP I-NP